KZR
- Kezar Life Sciences, Inc.
()
Overview
Company Summary
Kezar Life Sciences, Inc. (KZR) is a biotechnology company specializing in the discovery and development of novel small molecule therapeutics. The company focuses on developing innovative medicines that target protein homeostasis, which plays a crucial role in various diseases.
Kezar Life Sciences employs a unique approach that leverages the principles of protein degradation and modulation to tackle complex diseases with unmet medical needs. By targeting specific proteins involved in disease pathways, the company aims to restore balance and homeostasis to the affected biological systems.
One of the key areas of interest for Kezar Life Sciences is autoimmune diseases, where abnormal immune responses attack healthy tissues. They believe that by modulating the immune system and rebalancing protein pathways, they can potentially develop effective treatments for conditions such as systemic lupus erythematosus (SLE) and severe autoimmune hemolytic anemia (AIHA).
Additionally, Kezar Life Sciences is actively researching potential therapies for oncology indications. By targeting proteins associated with cancer progression and metastasis, the company aims to develop treatments that can impede tumor growth and improve patient outcomes.
Overall, Kezar Life Sciences is dedicated to advancing the field of protein homeostasis with the ultimate goal of developing groundbreaking therapies that address significant unmet medical needs across various disease areas.